fb

IMAC Holdings Completes First Infusion of Stem Cells in Clinical Study for the Treatment of Bradykinesia Due to Parkinson’s Disease

by | Dec 30, 2020 | Blog, David Price, DPC Homepage News, Featured News, IMAC Western Kentucky, In the Media, News, OSC Homepage News, Ozzie Smith, Uncategorized

BRENTWOOD, Tenn. (December 30, 2020) — IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or the “Company”), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic treatments without the use of surgery or opioids,...